COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

RSS icon

Policy experts call for renewed focus on cardiovascular disease, public health as COVID-19 crisis shows signs of improvement

The world has spent nearly two years now focused on the ongoing COVID-19 pandemic—and with good reason—but are other important healthcare issues now being ignored?

vaccine syringe covid-19 coronavirus

Freestanding imaging centers among those avoiding CMS’ COVID-19 vaccination mandate

The agency also did not include requirements for physician offices or portable X-ray suppliers, while some lawmakers plan to fight the emergency order.

Mild COVID-19 infections not associated with long-term risk of heart damage

The new study, published in JACC: Cardiovascular Imaging, suggests that asymptomatic individuals do not need to be screened after recovering from a mild COVID-19 diagnosis.

CMS finalizes COVID-19 vaccine mandate for healthcare workers, requiring full vaccination by Jan. 4

The policy covers all healthcare providers that participate in Medicare or Medicaid. 

coronavirus COVID-19 vaccine vaccination

COVID-19 vaccines are less effective on the immunocompromised

These individuals are less likely to benefit from COVID-19 vaccines, according to a recent study from the Centers for Disease Control and Prevention.

Thumbnail

STEMI patients with COVID-19 face an elevated risk of death

The new study, published in JAMA, examined patients presenting with both in-hospital and out-of-hospital STEMI.

kids in school

FDA authorizes Pfizer COVID-19 vaccine for children 5 to 11

The administration said it studied the vaccine's safety in more than 3,100 children, and no serious side effects have been reported thus far.

Thumbnail

No signs of heart damage after COVID-19 vaccination among younger children

Pfizer shared detailed clinical trial results with the FDA that highlight the effectiveness of its reduced-dose COVID-19 vaccine for children between the ages of 5 and 11. 

Displaying 393 - 400 of 934
Design by Adaptive Theme